BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29232468)

  • 1. The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications.
    Duska LR; Kohn EC
    Ann Oncol; 2017 Nov; 28(suppl_8):viii8-viii12. PubMed ID: 29232468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum].
    Šišovská I; Minář L; Felsinger M; Anton M; Bednaříková M; Hausnerová J; Jandáková E; Weinberger V
    Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications.
    Meinhold-Heerlein I; Fotopoulou C; Harter P; Kurzeder C; Mustea A; Wimberger P; Hauptmann S; Sehouli J
    Arch Gynecol Obstet; 2016 Apr; 293(4):695-700. PubMed ID: 26894303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer.
    Zeppernick F; Meinhold-Heerlein I
    Arch Gynecol Obstet; 2014 Nov; 290(5):839-42. PubMed ID: 25082067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New FIGO classification of ovarian, fallopian tube and primary peritoneal cancer].
    Höhn AK; Einenkel J; Wittekind C; Horn LC
    Pathologe; 2014 Jul; 35(4):322-6. PubMed ID: 24899496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The 2016 update of the S3 guideline for malignant tumours of the ovary : Role of pathology in diagnosis, therapy and clinical management of epithelial tumours].
    Staebler A; Mayr D
    Pathologe; 2017 Jul; 38(4):331-344. PubMed ID: 28664411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication.
    Prat J;
    J Gynecol Oncol; 2015 Apr; 26(2):87-9. PubMed ID: 25872889
    [No Abstract]   [Full Text] [Related]  

  • 8. Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer.
    Komiyama S; Katabuchi H; Mikami M; Nagase S; Okamoto A; Ito K; Morishige K; Suzuki N; Kaneuchi M; Yaegashi N; Udagawa Y; Yoshikawa H
    Int J Clin Oncol; 2016 Jun; 21(3):435-46. PubMed ID: 27142770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
    Rosendahl M; Høgdall CK; Mosgaard BJ
    Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013.
    Prat J
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):858-69. PubMed ID: 25890882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Revised FIGO Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum Based on a Single Histological Type.
    Toptas T; Pestereli E; Erol O; Bozkurt S; Erdogan G; Simsek T
    Int J Gynecol Cancer; 2016 Jul; 26(6):1012-9. PubMed ID: 27206284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa.
    Lavoue V; Huchon C; Akladios C; Alfonsi P; Bakrin N; Ballester M; Bendifallah S; Bolze PA; Bonnet F; Bourgin C; Chabbert-Buffet N; Collinet P; Courbiere B; De la Motte Rouge T; Devouassoux-Shisheboran M; Falandry C; Ferron G; Fournier L; Gladieff L; Golfier F; Gouy S; Guyon F; Lambaudie E; Leary A; Lecuru F; Lefrere-Belda MA; Leblanc E; Lemoine A; Narducci F; Ouldamer L; Pautier P; Planchamp F; Pouget N; Ray-Coquard I; Rousset-Jablonski C; Senechal-Davin C; Touboul C; Thomassin-Naggara I; Uzan C; You B; Daraï E
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():214-223. PubMed ID: 30905627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer of the ovary, fallopian tube, and peritoneum.
    Berek JS; Crum C; Friedlander M
    Int J Gynaecol Obstet; 2015 Oct; 131 Suppl 2():S111-22. PubMed ID: 26433667
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer of the ovary, fallopian tube, and peritoneum.
    Berek JS; Crum C; Friedlander M
    Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 2():S118-29. PubMed ID: 22999503
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer of the ovary, fallopian tube, and peritoneum.
    Berek JS; Kehoe ST; Kumar L; Friedlander M
    Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():59-78. PubMed ID: 30306591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists.
    Saida T; Tanaka YO; Matsumoto K; Satoh T; Yoshikawa H; Minami M
    Jpn J Radiol; 2016 Feb; 34(2):117-24. PubMed ID: 26696400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum.
    Singh N; Gilks CB; Wilkinson N; McCluggage WG
    Histopathology; 2015 Sep; 67(3):331-7. PubMed ID: 25640750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of peritoneal washing cytology in staging and prognosis of ovarian and fallopian tube neoplasms: a 10-year retrospective analysis.
    Davidson W; Madan R; O'Neil M; Tawfik OW; Fan F
    Ann Diagn Pathol; 2016 Jun; 22():54-7. PubMed ID: 27180061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
    Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
    Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.